Onfi (Lundbeck Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Onfi drug offered from Lundbeck Pharmaceuticals LLC. This Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lundbeck Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | clobazam |
| SUBSTANCE NAME: | CLOBAZAM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Cytochrome P450 2D6 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-12-14 |
| END MARKETING DATE: | 0000-00-00 |
Onfi HUMAN PRESCRIPTION DRUG Details:
| Item Description | Onfi from Lundbeck Pharmaceuticals LLC |
| LABELER NAME: | Lundbeck Pharmaceuticals LLC |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 2.5(mg/mL) |
| START MARKETING DATE: | 2012-12-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67386-313_58d32c2a-ca28-49cb-98f5-57cee4f42b42 |
| PRODUCT NDC: | 67386-313 |
| APPLICATION NUMBER: | NDA203993 |
Other CLOBAZAM Pharmaceutical Manufacturers / Labelers:
